Acceleron Pharma
XLRN
#1831
Rank
โ‚ฌ9.31 B
Marketcap
152,26ย โ‚ฌ
Share price
0.00%
Change (1 day)
13,415.49%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.25 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ96.05 Million. In 2020 the company made a revenue of โ‚ฌ78.81 Million an increase over the revenue in the year 2019 that were of โ‚ฌ63.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.25 M20.85%
2020โ‚ฌ78.81 M25.05%
2019โ‚ฌ63.02 M428.85%
2018โ‚ฌ11.91 M3.78%
2017โ‚ฌ11.48 M-51.45%
2016โ‚ฌ23.65 M53.47%
2015โ‚ฌ15.41 M23.68%
2014โ‚ฌ12.46 M-74.43%
2013โ‚ฌ48.74 M275.17%
2012โ‚ฌ12.99 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ30.64 B 31,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ12.13 B 12,535.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ78.49 B 81,618.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ28 M-70.85%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ88.54 M-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.48 B 55,579.12%๐Ÿ‡บ๐Ÿ‡ธ USA